AQR Capital Management’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$107K Buy
+66,156
New +$136K ﹤0.01% 3680
2025
Q4
Sell
-48,281
Closed -$99.5K 3584
2025
Q3
$99.5K Buy
48,281
+29,360
+155% +$81.1K ﹤0.01% 3370
2025
Q2
$59.6K Sell
18,921
-10,262
-35% -$31.3K ﹤0.01% 3229
2025
Q1
$91.6K Sell
29,183
-11,456
-28% -$45.3K ﹤0.01% 3025
2024
Q4
$176K Buy
40,639
+9,770
+32% +$30.5K ﹤0.01% 2696
2024
Q3
$82.4K Buy
+30,869
New +$72.9K ﹤0.01% 2670
2022
Q3
Sell
-54,580
Closed -$120K 2219
2022
Q2
$120K Sell
54,580
-308,703
-85% -$517K ﹤0.01% 2066
2022
Q1
$901K Buy
363,283
+330,006
+992% +$1.17M ﹤0.01% 1594
2021
Q4
$200K Sell
33,277
-2,776
-8% -$16.5K ﹤0.01% 2088
2021
Q3
$240K Buy
+36,053
New +$226K ﹤0.01% 2103

Other funds holding CRDF